Struggling UniQure Cuts Gene Therapies, Jobs, in Big Restructuring – Xconomy
Xconomy |
Struggling UniQure Cuts Gene Therapies, Jobs, in Big Restructuring
Xconomy UniQure may have been the first company to win approval of a gene therapy, but that hasn't translated to commercial success or a booming share price. Now it's cutting jobs and restructuring to try to gain some momentum. Amsterdam- and Lexington … |
